Trevi Therapeutics (TRVI)
Developing oral nalbuphine ER across three chronic-cough indications.
$15.18
vs last close+0.29 (+1.94%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 51 days
EPS estimate
−$0.13
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.11−$0.09−$0.09−$0.08−$0.06−$0.09−$0.11Pending
Estimate−$0.12−$0.13−$0.10−$0.10−$0.10−$0.07−$0.11−$0.13
Surprise+8.3%+30.8%+10.0%+20.0%+40.0%−28.6%−0.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.27 | — | — |
| Sep 2028 | $0.26 | — | — |
| Jun 2028 | $0.26 | — | — |
| Mar 2028 | $0.25 | — | — |
| Dec 2027 | −$0.21 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.17 | — | — |
| Mar 2027 | −$0.16 | — | — |
| Dec 2026 | −$0.14 | — | — |
| Nov 2026 | −$0.13 | — | — |
| Aug 2026 | −$0.11 | −$0.11 | −0.5% |
| May 2026 | −$0.07 | −$0.09 | −28.6% |
| Mar 2026 | −$0.10 | −$0.06 | +40.0% |
| Nov 2025 | −$0.10 | −$0.08 | +20.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Jun 2019 | |||
| May 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.27 | — | — | $67.6M | — | — | — |
| Sep 2028 | $0.26 | — | — | $63.7M | — | — | — |
| Jun 2028 | $0.26 | — | — | $62.5M | — | — | — |
| Mar 2028 | $0.25 | — | — | $61.2M | — | — | — |
| Dec 2027 | −$0.21 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.19 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.17 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.16 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.14 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$0.13 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.11 | −$0.11 | −0.5% | — | — | — | +0.1% |
| May 5, 2026 | −$0.07 | −$0.09 | −28.6% | — | — | — | −2.7% |
| Mar 17, 2026 | −$0.10 | −$0.06 | +40.0% | — | — | — | −4.5% |
| Nov 13, 2025 | −$0.10 | −$0.08 | +20.0% | — | — | — | −0.8% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 20, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 12, 2019 | |||||||
| Jun 13, 2019 | |||||||
| May 8, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 |